Skip to main content

Table 4 New manufacturing method overall efficiency: improved contaminants' removal

From: Bone marrow-derived cells for cardiovascular cell therapy: an optimized GMP method based on low-density gradient improves cell purity and function

  % PLT removal % GRA removal % MNC yield
Current method (n = 43)a 89 ± 7 91 ± 4 25 ± 11
New method (n = 24)b 97 ± 1** 95 ± 3** 13 ± 7**
  1. Data are reported as mean ± standard deviation.
  2. PLT: Platelets; GRA: Granulocytes; MNC: Mononuclear cells (lymphocytes +μmonocytes).
  3. ailiac crest samples (n = 33) + sternal samples (n = 10); bsternal samples only; **p < 0.01 (unpaired T-test).
\